Differential gene expression identifies novel markers of CD4+ and CD8+ T cell activation following stimulation by Mycobacterium tuberculosis

Journal of Immunology

Volumn 173, Issue 1, 2004, Pages 485-493

  Cliff, Jacqueline M ^a   Andrade, Iryna N J ^a   Mistry, Rohit ^b,c   Clayton, Christopher L ^b   Lennon, Mark G ^b   Lewis, Alan P ^b   Duncan, Ken ^b   Lukey, Pauline T ^b   Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; MYCOBACTERIUM VACCINE;

ARTICLE; BACTERIAL INFECTION; BIOINFORMATICS; CELL FUNCTION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UNINDEXED SEQUENCE;

EID: 2942744661     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.1.485     Document Type: Article

References (52)

1. Croft, M., L. Carter, S. L. Swain, and R. W. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
2. Teague, T. K., D. Hildeman, R. M. Kedl, T. Mitchell, W. Rees, B. C. Schaefer. J. Bender, J. Kappler, and P. Marrack. 1999. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA 96:12691.
3. + suppressor T cells in vivo. Nat. Immunol. 3:33.
4. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
5. Rogge, L., E. Bianchi, M. Biffi, E. Bono, S. Y. Chang, H. Alexander, C. Santini, G. Ferrari, L. Sinigaglia, M. Seiler, et al. 2000. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25:96.
6. + type 1 and type 2 T cells. J. Immunol. 167:3057.
7. Beadling, C., and K. A. Smith. 2002. DNA array analysis of interleukin-2-regulated immediate/early genes. Med. Immunol. 1:2.
8. Diehn, M., A. A. Alizadeb, O. J. Rando, C. L. Liu, K. Stankunas, D. Botstein, G. R. Crabtree, and P. O. Brown. 2002. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 99:11796.
9. Riley, J. L., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. P. Gregson, C. H. June, and P. S. Linsley. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99:11790.
10. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project. J. Am. Med. Assoc. 282:677.
11. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339.
12. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2. J. Exp. Med. 192:347.
13. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.
14. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013.
15. van Pinxteren, L. A., J. P. Cassidy, B. H. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30:3689.
16. + CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165:7088.
17. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270.
18. + T cells. Infect. Immun. 67:5223.
19. + T cells in vitro. Immunology 87:339.
20. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121.
21. Lorgat, F., M. M. Keraan, P. T. Lukey, and S. R. Ress. 1992. Evidence for in vivo generation of cytotoxic T cells: PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am. Rev. Respir. Dis. 145:418.
22. + T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β. Infect. Immun. 67:6461.
23. Hirsch, C. S., Z. Toossi, C. Othieno, J. L. Johnson, S. K. Schwander, S. Robertson, R. S. Wallis, K. Edmonds, A. Okwera, R. Mugerwa, et al. 1999. Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180:2069.
24. + T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis 82:7.
25. + T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect. Immun. 68:7144.
26. Kittler, J. T., E. V. Grigorenko, C. Clayton, S. Y. Zhuang, S. C. Bundey, M. M. Trower, D. Wallace, R. Hampson, and S. Deadwyler. 2000. Large-scale analysis of gene expression changes during acute and chronic exposure to δ9-THC in rats. Physiol. Genomics 3:175.
27. Cox, J. M., C. L. Clayton, T. Tomita, D. M. Wallace, P. A. Robinson, and J. E. Crabtree. 2001. cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect. Immun. 69:6970.
28. Snedecor, G. W., and W. G. Cochran. 1989. Statistical Methods. Iowa State University Press, Ames.
29. Moller, S., M. D. Croning, and R. Apweiler. 2001. Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17:646.
30. Nielsen, H., J. Engelbrecht, S. Brunak, and G. von Heijne. 1997. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1.
31. Nakai, K., and M. Kanehisa. 1992. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 14:897.
32. Falquet, L., M. Pagni, P. Bucher, N. Hulo, C. J. Sigrist, K. Hofmann, and A. Bairoch. 2002. The PROSITE database, its status in 2002. Nucleic Acids Res. 30:235.
33. Bateman, A., E. Birney, L. Cerruti, R. Durbin, L. Etwiller, S. R. Eddy, S. Griffiths-Jones, K. L. Howe, M. Marshall, and E. L. Sonnhammer. 2002. The Pfam protein families database. Nucleic Acids Res. 30:276.
34. Attwood, T. K., P. Bradley, D. R. Flower, A. Gaulton, N. Maudling, A. L. Mitchell, G. Moulton, A. Nordle, K. Paine, P. Taylor, et al. 2003. PRINTS and its automatic supplement, prePRINTS. Nucleic Acids Res. 31:400.
35. Letunic, I., L. Goodstadt, N. J. Dickens, T. Doerks, J. Schultz, R. Mott, F. Ciccarelli, R. R. Copley, C. P. Ponting, and P. Bork. 2002. Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res. 30:242.
36. Black, G. F., R. E. Weir, S. Floyd, L. Bliss, D. K. Warndorff, A. C. Crampin, B. Ngwira, L. Sichali, B. Nazareth, J. M. Blackwell, et al. 2002. BCG-induced increase in interferon-γ response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomized controlled studies. Lancet 359:1393.
37. Pruitt, K. D., K. S. Katz, H. Sicotte, and D. R. Maglott. 2000. Introducing RefSeq and LocusLink: curated human genome resources at the NCB1. Trends Genet. 16:44.
38. Turner, J., M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169:6343.
39. Olobo, J. O., M. Geletu, A. Demissie, T. Eguale, K. Hiwot, G. Aderaye, and S. Britton. 2001. Circulating TNF-α, TGF-β, and IL-10 in tuberculosis patients and healthy contacts. Scand. J. Immunol. 53:85.
40. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255.
41. Das, H., V. Groh, C. Kuijl, M. Sugita, C. T. Morita, T. Spies, and J. F. Bukowski. 2001. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15:83.
42. Prlic, M., L. Lefrancois, and S. C. Jameson. 2002. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195:F49.
43. Barnaba, V., C. Watts, M. de Boer, P. Lane, and A. Lanzavecchia. 1994. Professional presentation of antigen by activated human T cells. Eur. J. Immunol. 24:71.
44. + T cells is activation dependent. J. Immunol. 162:1287.
45. Dittie, A. S., L. Thomas, G. Thomas, and S. A. Tooze. 1997. Interaction of furin in immature secretory granules from neuroendocrine cells with the AP-1 adaptor complex is modulated by casein kinase II phosphorylation. EMBO J. 16:4859.
46. Wang, X., L. M. Johansen, H. J. Tae, and E. J. Taparowsky. 1996. IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors. Biochem. Biophys. Res. Commun. 229:316.
47. + cytotoxic T cells and relafive resistance of alveolar macrophages to lysis. Immunol. 159:290.
48. Ogawa, K., K. Tanaka, A. Ishii, Y. Nakamura, S. Kondo, K. Sugamura, S. Takano, M. Nakamura, and K. Nagata. 2001. A novel serum protein that is selectively produced by cytotoxic lymphocytes. J. Immunol. 166:6404.
49. Orme, I. M. 2001. The search for new vaccines against tuberculosis. J. Leukocyte Biol. 70:1.
50. Ellner, J. J., C. S. Hirsch, and C. C. Whalen. 2000. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin. Infect. Dis. 30 (Suppl. 3):S279.
51. Skinner, M. A., A. J. Ramsay, G. S. Buchan, D. L. Keen, C. Ranasinghe, L. Slobbe, D. M. Collins, G. W. de Lisle, and B. M. Buddle. 2003. A DNA prime-live vaccine boost strategy in mice can augment IFN-γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis. Immunology 108:548.
52. Kampmann, B., P. O. Gaora, V. A. Snewin, M. P. Gares, D. B. Young, and M. Levin. 2000. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J. Infect. Dis. 182:895.